McKesson Corporation
NYSE:MCK
Sector
Location
Market Cap
USD 89.30 B
Share Price
USD 714.92
Avg Daily Volume
932,138
Change (1 day)
0.39%
Change (1 year)
17.25%
Change (YTD)
25.44%
McKesson Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 6.08 B
McKesson Corporation Operating Cash Flow is USD 6.08 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 41.05% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
McKesson Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 4.31 B, a -16.38% change year over year.
-
McKesson Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 5.16 B, a 16.35% change year over year.
-
McKesson Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 4.43 B, a -2.38% change year over year.
-
McKesson Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 4.54 B, a 3.84% change year over year.
StockViz
Competitors
Merck & Co., Inc.
USD 81.75
MRK
-0.88
-1.06%
Elevance Health Inc.
USD 293.55
ELV
+4.82
1.67%
Cencora, Inc.
USD 291.80
COR
+2.03
0.70%
BeOne Medicines Ltd.
USD 299.94
ONC
-5.80
-1.90%
JD Health International Inc.
USD 6.44
6618.HK
+0.04
0.61%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.49
2196.HK
-0.03
-1.00%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.61
2607.HK
-0.03
-1.70%
Haisco Pharmaceutical Group Co., Ltd.
USD 7.74
002653.SZ
+0.50
6.87%
Sinopharm Group Co. Ltd.
USD 2.42
1099.HK
-0.08
-3.35%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.32
0874.HK
-0.01
-0.64%
Hikma Pharmaceuticals PLC
USD 26.40
HIK.L
+0.04
0.14%
Galenica AG
USD 106.75
GALE.SW
-2.16
-1.99%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.05
600079.SS
-0.01
-0.18%
Option Care Health, Inc.
USD 30.64
OPCH
+0.51
1.69%
China Resources Pharmaceutical Group Limited
USD 0.70
3320.HK
-0.01
-1.94%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Merck & Co., Inc.
USD 81.75
MRK
-0.88
-1.06%
Elevance Health Inc.
USD 293.55
ELV
+4.82
1.67%
Cencora, Inc.
USD 291.80
COR
+2.03
0.70%
BeOne Medicines Ltd.
USD 299.94
ONC
-5.80
-1.90%
JD Health International Inc.
USD 6.44
6618.HK
+0.04
0.61%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.49
2196.HK
-0.03
-1.00%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.61
2607.HK
-0.03
-1.70%
Haisco Pharmaceutical Group Co., Ltd.
USD 7.74
002653.SZ
+0.50
6.87%
Sinopharm Group Co. Ltd.
USD 2.42
1099.HK
-0.08
-3.35%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.32
0874.HK
-0.01
-0.64%
Hikma Pharmaceuticals PLC
USD 26.40
HIK.L
+0.04
0.14%
Galenica AG
USD 106.75
GALE.SW
-2.16
-1.99%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.05
600079.SS
-0.01
-0.18%
Option Care Health, Inc.
USD 30.64
OPCH
+0.51
1.69%
China Resources Pharmaceutical Group Limited
USD 0.70
3320.HK
-0.01
-1.94%